Skip to main content
. 2007 Apr;16(4):662–670. doi: 10.1110/ps.062666607

Figure 1.

Figure 1.

SDS-PAGE (12% Tris-glycine) of the purified Leu67Tyr/Ala205Leu cathepsin L mutant. (Lane 1) Crude supernatant fraction of the human Leu67Tyr/Ala205Leu mutant from P. pastoris; (lane 2) activation of the precursor mutant by treatment with pepsin; (lane 3) purified Leu67Tyr/Ala205Leu mutant after passage through the Butyl-Sepharose column; (lane 4) purified recombinant wild-type human cathepsin L. Molecular mass standards are reported in the left lane (Coomassie-blue staining).